The emergence of antibiotic resistance, even against last-line antibiotics such as colistin, is a serious public health threat. To guide treatment and drug development strategies, Marciano et al. apply evolutionary action (EA) analysis to identify driver mutations in a noisy mutational background in experimental evolution experiments and inform about de novo colistin resistance drivers.
- David C. Marciano
- Chen Wang
- Olivier Lichtarge
